Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05445609
Title Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Recruitment Suspended
Gender male
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.